Botaneco Announces Appointment of CEO

Successful Entrepreneur and Investor to Lead Growth of Company 

QUEBEC CITY, May 30, 2012 /CNW/ - Botaneco Corp. ("Botaneco") (TSX-V:BOT), a health science company focused on natural proprietary ingredients in the cosmetic and food industries, today announces the appointment of Michelle Scarborough as Chief Executive Officer ("CEO") of the Corporation effective immediately.  Michelle has held a cross section of executive roles in public and private sector organizations, positioning these companies to achieve significant milestones, investment and growth.  She is currently Managing Partner of SMART Ventures, LP, a fund that invests in cleantech, energy, ICT and related sectors

"We are excited that Michelle is joining Botaneco in a senior leadership capacity," stated Aki Georgacacos, current CEO of Botaneco.  "Her long track record of success, exceptional leadership, interpersonal and organizational skills, along with strong ties to the investment community, will guide Botaneco through the upcoming stages of development and beyond." 

Mr. Georgacacos will remain on the Board of Directors and will be in an advisory capacity to assist in the implementation of the Corporations strategic plan.  Aki is currently a managing partner at Avrio Capital, a lead investor in Botaneco.

"Botaneco has excellent proprietary technology in the personal healthcare / cosmetic and food industry.  This is evident by the existing partnerships and over 300 products in the market place where Botaneco's technology is used" stated Ms. Scarborough.  "The company is poised for exceptional growth and I look forward to leveraging my experience and connections in the business and investment community in order to maximize shareholder value for this very promising organization." 

About Michelle Scarborough  

Over the past 20 years Michelle has been an entrepreneur and built successful companies from the ground up.  To foster the growth in early stage companies, she designed and built a business accelerator in Ontario whose portfolio of companies raised close to $100 million in investment over a four year period.  Active in the investment community, she also established the Ontario Emerging Technology Fund, a $250 million early stage fund and founded the Capital Angel Network. She also founded and continues to champion the Canada's Top 10 Competition (www.topcanadiancompanies.com), which identifies and celebrates some of the best investment opportunities in Canada. To date these companies have raised more than $700 million in capital. 

Michelle graduated from the University of Calgary with dual bachelor designations in Science and Communications.  She is a 2008 Top 40 Under 40 Award Recipient and is Chair of the National Angel Capital Organization in Canada.  She is a regular speaker at conferences and in the media on topics related to early stage investment, commercialization and building global business from the early stage.

About Botaneco Corp.

Botaneco is a global developer and marketer of innovative technologies that help manufacturers meet the consumers growing demand for natural, environmentally friendly, personal healthcare products.  A competitive advantage to Botaneco's patented technology over traditional products in the 'green sector' is the ability to significantly enhance the performance and versatility of these skin and hair care products.  The company has also been awarded the Canadian Agri-Food Award of Excellence for its flaxseed technology marketed in the natural food industry.  Botaneco holds patents for its Hydresia® Oleosome, Vegetable Oil Gel, Dermylex® Whey Protein and Flaxseed De-hulling technology.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
 

Murray Bruce
CFO
Botaneco Corp.
[phone]
[email protected] 

Kevin Richardson, PhD
President & CEO
Newplanet Inc
[phone]
[email protected]